These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 19487224

  • 1. Cardiac complications of systemic sclerosis.
    Kahan A, Coghlan G, McLaughlin V.
    Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii45-8. PubMed ID: 19487224
    [Abstract] [Full Text] [Related]

  • 2. Primary myocardial involvement in systemic sclerosis.
    Kahan A, Allanore Y.
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 4():iv14-7. PubMed ID: 16980717
    [Abstract] [Full Text] [Related]

  • 3. Outcome measures for heart involvement in systemic sclerosis.
    Allanore Y, Meune C, Kahan A.
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v51-3. PubMed ID: 18784146
    [Abstract] [Full Text] [Related]

  • 4. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
    Sergiacomi G, De Nardo D, Capria A, Manenti G, Fabiano S, Borzi M, De Sanctis G, Konda D, Sperandio M, Schillaci O, Masala S, Simonetti G, Fontana L.
    In Vivo; 2004 Oct; 18(2):229-35. PubMed ID: 15113051
    [Abstract] [Full Text] [Related]

  • 5. [Cardiopathy in systemic sclerosis].
    Valentini G, Maione S.
    Recenti Prog Med; 1996 Nov; 87(11):557-63. PubMed ID: 9122540
    [Abstract] [Full Text] [Related]

  • 6. Systemic sclerosis/scleroderma: a treatable multisystem disease.
    Hinchcliff M, Varga J.
    Am Fam Physician; 2008 Oct 15; 78(8):961-8. PubMed ID: 18953973
    [Abstract] [Full Text] [Related]

  • 7. [Heart involvement in systemic sclerosis: analysis of four cases].
    Wielosz E, Borys O, Błaszczak P, Majdan M.
    Ann Acad Med Stetin; 2012 Oct 15; 58(1):33-9; discussion 39. PubMed ID: 23547392
    [Abstract] [Full Text] [Related]

  • 8. [Cardiac and pulmonary involvement in scleroderma].
    Launay D, Hachulla E.
    Rev Prat; 2002 Nov 01; 52(17):1901-7. PubMed ID: 12532867
    [Abstract] [Full Text] [Related]

  • 9. Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies.
    Meune C, Vignaux O, Kahan A, Allanore Y.
    Arch Cardiovasc Dis; 2010 Jan 01; 103(1):46-52. PubMed ID: 20142120
    [Abstract] [Full Text] [Related]

  • 10. Current options for the treatment of systemic scleroderma.
    McGee BA, Barnett MD, Small RE.
    Clin Pharm; 1991 Jan 01; 10(1):14-25. PubMed ID: 1999084
    [Abstract] [Full Text] [Related]

  • 11. Cardiac involvement in systemic sclerosis.
    Balaj R, Poanta L, Rednic S.
    Rom J Intern Med; 2012 Jan 01; 50(4):269-74. PubMed ID: 23610974
    [Abstract] [Full Text] [Related]

  • 12. [Systemic sclerosis].
    Tamborrini G, Distler M, Distler O.
    Med Monatsschr Pharm; 2008 May 01; 31(5):162-70; quiz 171-2. PubMed ID: 18552072
    [Abstract] [Full Text] [Related]

  • 13. The manifestations of vasculopathy in systemic sclerosis and its evidence-based therapy.
    Strange G, Nash P.
    Int J Rheum Dis; 2009 Sep 01; 12(3):192-206. PubMed ID: 20374346
    [Abstract] [Full Text] [Related]

  • 14. Systemic sclerosis and cardiac dysfunction: evolving concepts and diagnostic methodologies.
    Allanore Y, Meune C, Kahan A.
    Curr Opin Rheumatol; 2008 Nov 01; 20(6):697-702. PubMed ID: 18946331
    [Abstract] [Full Text] [Related]

  • 15. Future targets in the management of systemic sclerosis.
    Tyndall A, Matucci-Cerinic M, Müller-Ladner U.
    Rheumatology (Oxford); 2009 Jun 01; 48 Suppl 3():iii49-53. PubMed ID: 19487225
    [Abstract] [Full Text] [Related]

  • 16. Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register.
    Hanitsch LG, Burmester GR, Witt C, Hunzelmann N, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, Müller-Ladner U, Schulze-Lohoff E, Becker M, Sunderkoetter C, DNSS centers, Riemekasten G.
    Rheumatology (Oxford); 2009 Jan 01; 48(1):70-3. PubMed ID: 19056798
    [Abstract] [Full Text] [Related]

  • 17. [Heart involvement and pulmonary arterial hypertension in patients with systemic sclerosis].
    Cikes N.
    Reumatizam; 2010 Jan 01; 57(2):99-104. PubMed ID: 21875012
    [Abstract] [Full Text] [Related]

  • 18. Pulmonary complications: one of the most challenging complications of systemic sclerosis.
    Wells AU, Steen V, Valentini G.
    Rheumatology (Oxford); 2009 Jun 01; 48 Suppl 3():iii40-4. PubMed ID: 19487223
    [Abstract] [Full Text] [Related]

  • 19. Vasoactive therapies in systemic sclerosis.
    Riemekasten G, Sunderkötter C.
    Rheumatology (Oxford); 2006 Oct 01; 45 Suppl 3():iii49-51. PubMed ID: 16987836
    [Abstract] [Full Text] [Related]

  • 20. Micro- and macrovascular treatment targets in scleroderma heart disease.
    Dimitroulas T, Giannakoulas G, Karvounis H, Garyfallos A, Settas L, Kitas GD.
    Curr Pharm Des; 2014 Oct 01; 20(4):536-44. PubMed ID: 23565639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.